Because SMYD1 is a muscle-specific histone methyltransferase, we suspected that the CKO phenotype would, at least in part, result from altered epigenetic regulation/transcription of genes known to cause CNM. The gene discussed is PRDM9; the disease is centronuclear myopathy.